These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 17033748

  • 1. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y, Li JB, Ye DQ, Jiang ZJ.
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [Abstract] [Full Text] [Related]

  • 2. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW.
    Clin Infect Dis; 2004 Sep 15; 39(6):812-8. PubMed ID: 15472813
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC, Chen TL, Ju HL, Chen HS, Wang FD, Yu KW, Liu CY.
    J Microbiol Immunol Infect; 2006 Feb 15; 39(1):67-72. PubMed ID: 16440126
    [Abstract] [Full Text] [Related]

  • 4. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
    Chang EP, Chiang DH, Lin ML, Chen TL, Wang FD, Liu CY.
    J Microbiol Immunol Infect; 2009 Aug 15; 42(4):329-35. PubMed ID: 19949757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 15; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enterobacter bacteremia.
    Gupta N, Aparna, Choudhary U, Garg N, Arora DR.
    J Assoc Physicians India; 2003 Jul 15; 51():669-72. PubMed ID: 14621034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fusobacterium bacteremia: clinical significance and outcomes.
    Su CP, Huang PY, Yang CC, Lee MH.
    J Microbiol Immunol Infect; 2009 Aug 15; 42(4):336-42. PubMed ID: 19949758
    [Abstract] [Full Text] [Related]

  • 18. Group A streptococcal bacteremia: outcome and prognostic factors.
    Vallalta Morales M, Soriano Navarro CJ, Salavert Lletí M, Montero Alonso M, Pérez Bellés C, López Aldeguer J, Otero MC, Gobernado Serrano M.
    Rev Esp Quimioter; 2006 Dec 15; 19(4):367-75. PubMed ID: 17235407
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years].
    Ruiz-Giardín JM, Noguerado A, Pizarro A, Méndez J, La Hulla F, Fernández M, Hernández F, San Martín JV, Hernández I, Alvarez J, Salvanes F.
    Enferm Infecc Microbiol Clin; 2002 Nov 15; 20(9):435-42. PubMed ID: 12425877
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.